Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32351 | 109 | 37.5 | 89% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1187 | 8873 | RESTENOSIS//INTRAVASCULAR BRACHYTHERAPY//TRANILAST |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CELLULAR REPRESSOR OF E1A STIMULATED GENES | Author keyword | 14 | 100% | 6% | 7 |
| 2 | CREG | Author keyword | 6 | 50% | 8% | 9 |
| 3 | CELLULAR REPRESSOR OF E1A STIMULATED GENES CREG | Author keyword | 6 | 100% | 4% | 4 |
| 4 | REPRESSOR PROTEIN | Author keyword | 3 | 30% | 6% | 7 |
| 5 | ADVENTITIAL FIBROBLASTS | Author keyword | 2 | 24% | 7% | 8 |
| 6 | CREG1 | Author keyword | 1 | 100% | 2% | 2 |
| 7 | SHENYANG GEN HOSP | Address | 1 | 33% | 3% | 3 |
| 8 | ADVENTITIAL FIBROBLAST | Author keyword | 1 | 19% | 4% | 4 |
| 9 | PROTEOLYTIC MATURATION | Author keyword | 1 | 33% | 2% | 2 |
| 10 | BIOSCI TECHNOLHLTH SCI | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | E1A STIMULATED GENES | 37 | 100% | 13% | 14 |
| 2 | CELLULAR REPRESSOR | 17 | 79% | 10% | 11 |
| 3 | CREG | 6 | 58% | 6% | 7 |
| 4 | STEROID INDUCED HYPERTENSION | 1 | 50% | 1% | 1 |
| 5 | CORONARY REVASCULARIZATION 1999 | 0 | 25% | 1% | 1 |
| 6 | RS447 | 0 | 25% | 1% | 1 |
| 7 | ADVENTITIAL MYOFIBROBLASTS | 0 | 14% | 1% | 1 |
| 8 | HEXAMETHYLENE BISACETAMIDE HMBA | 0 | 14% | 1% | 1 |
| 9 | INTIMAL LESIONS | 0 | 14% | 1% | 1 |
| 10 | EXTRACYTOPLASMIC REGION | 0 | 10% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| CREG: A Possible Candidate for Both Prevention and Treatment of Proliferative Vascular Disease | 2012 | 1 | 60 | 42% |
| Adventitial growth factor signalling and vascular remodelling: Potential of perivascular gene transfer from the outside-in | 2007 | 39 | 101 | 7% |
| Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm | 2010 | 37 | 107 | 6% |
| Application of laser capture microdissection and differential display technique for screening of pathogenic genes involved in endometrial carcinoma | 2007 | 4 | 14 | 14% |
| Contribution of adventitial fibroblasts to neointima formation and vascular remodeling - From innocent bystander to active participant | 2001 | 267 | 111 | 5% |
| Vascular myofibroblasts - Lessons from coronary repair and remodeling | 1997 | 122 | 40 | 3% |
| Metabolic syndrome and chronic vascular disease - Cell mechanisms and potential candidate genes | 1996 | 1 | 76 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SHENYANG GEN HOSP | 1 | 33% | 2.8% | 3 |
| 2 | BIOSCI TECHNOLHLTH SCI | 1 | 50% | 0.9% | 1 |
| 3 | ROBERT WOOD JOHNSON MED OOL | 1 | 50% | 0.9% | 1 |
| 4 | SHANGHAI HYPERTENSSHANGHAI VASC BIO | 1 | 50% | 0.9% | 1 |
| 5 | BRAIN SCISTATE MED NEUROBIOL | 0 | 33% | 0.9% | 1 |
| 6 | GYNECOL ONCOL SHANDONG PROV | 0 | 33% | 0.9% | 1 |
| 7 | LONDON HLTH SCI BIOCHEM | 0 | 33% | 0.9% | 1 |
| 8 | LONDON HLTH SCI MED BIOPHYS | 0 | 33% | 0.9% | 1 |
| 9 | LONDON HLTH SCI MED CARDIOL | 0 | 33% | 0.9% | 1 |
| 10 | MASSACHUSETTES GEN HOSP | 0 | 33% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000241158 | CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS |
| 2 | 0.0000136299 | SMOOTHELIN//SMTNL1//SMEMB |
| 3 | 0.0000134328 | LOCAL DRUG DELIVERY//HIRULOG LIKE PEPTIDE//ANGIOPEPTIN |
| 4 | 0.0000128150 | I CELL DISEASE//MANNOSE 6 PHOSPHATE//MUCOLIPIDOSIS TYPE III |
| 5 | 0.0000123267 | VASA VASORUM//UNITAT DETECCIO TRACTAMENT MALALTIES ATEROTROMB//PLAQUE NEOVASCULARIZATION |
| 6 | 0.0000119741 | RAT AORTIC SMOOTH MUSCLE CELL//CINNAMOMUM CASSIA BARK//CLITOCYBIN A |
| 7 | 0.0000115182 | SALICYLIDENEAMINO 2 THIOPHENOL//GAMABUFOTALIN//INFLAMMATION CONTROL |
| 8 | 0.0000099295 | GLC OXLDL//MOL VASC CELL BIOL//PATHOL AZ MIDDELHEIM |
| 9 | 0.0000091091 | CTRP3//CTRP 3//CTRP5 |
| 10 | 0.0000090849 | VICTORIA JOHNSON//VCU PAULEY HEART//VICTORIA JOHNSON S |